Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages

Abstract Chitosan is a family of glucosamine and N -acetyl glucosamine polysaccharides with poorly understood immune modulating properties. Here, functional U937 macrophage responses were analyzed in response to a novel library of twenty chitosans with controlled degree of deacetylation (DDA, 60–98%...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials 2017-06, Vol.129, p.127-138
Hauptverfasser: Fong, David, Grégoire-Gélinas, Pascal, Cheng, Alexandre P, Mezheritsky, Tal, Lavertu, Marc, Sato, Sachiko, Hoemann, Caroline D., Ph.D., P.Eng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 138
container_issue
container_start_page 127
container_title Biomaterials
container_volume 129
creator Fong, David
Grégoire-Gélinas, Pascal
Cheng, Alexandre P
Mezheritsky, Tal
Lavertu, Marc
Sato, Sachiko
Hoemann, Caroline D., Ph.D., P.Eng
description Abstract Chitosan is a family of glucosamine and N -acetyl glucosamine polysaccharides with poorly understood immune modulating properties. Here, functional U937 macrophage responses were analyzed in response to a novel library of twenty chitosans with controlled degree of deacetylation (DDA, 60–98%), molecular weight (1 to >100 kDa), and acetylation pattern (block vs. random). Specific chitosan preparations (10 or 190 kDa 80% block DDA and 3, 5, or 10 kDa 98% DDA) either induced macrophages to release CXCL10 and IL-1ra at 5–50 μg/mL, or activated the inflammasome to release IL-1β and PGE2 at 50–150 μg/mL. Chitosan induction of these factors required lysosomal acidification. CXCL10 production was preceded by lysosomal rupture as shown by time-dependent co-localization of galectin-3 and chitosan and slowed autophagy flux, and specifically depended on IFN-β paracrine activity and STAT2 activation that could be suppressed by PGE2 . Chitosan induced a type I IFN paracrine response or inflammasome response depending on the extent of lysosomal rupture and cytosolic foreign body invasion. This study identifies the structural motifs that lead to chitosan-driven cytokine responses in macrophages and indicates that lysosomal rupture is a key mechanism that determines the endogenous release of either IL-1ra or IL-1β.
doi_str_mv 10.1016/j.biomaterials.2017.03.022
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1881267897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0142961217301667</els_id><sourcerecordid>1881267897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c553t-24b6342b3abb70c9a7e947595965242c01fc680d3816d18aa259588e82466fd73</originalsourceid><addsrcrecordid>eNqNUs1u1DAQthCILoVXQBYnLgn-SRyHAxJqKVRawQE4W44zy3pJ4uBxKuUpeGUcbUGIEydrPN_PjL4h5AVnJWdcvTqVnQ-jTRC9HbAUjDclkyUT4gHZcd3oom5Z_ZDsGK9E0SouLsgTxBPLNavEY3IhtKyYrPWO_NyvGDCrDTQuc1oiUD_1i4OedivFFBeXP-0wrLT3mPzkEnVHnwLaCSn4dIRI5xjGkACppWmdgXJ6e_ORRsA5TAg0RGpd8nd2g2RCdjgMdhxt9t0KOloXw3y03wCfkkeHvBQ8u38vydebd1-uPhT7T-9vr97uC1fXMhWi6pSsRCdt1zXMtbaBtmrqtm5VLSrhGD84pVkvNVc919aK3NMatKiUOvSNvCQvz7p59h8LYDKjRwfDYCcICxquNReq0e0GfX2G5iERIxzMHP1o42o4M1sg5mT-DsRsgRgmTQ4kk5_f-yzdCP0f6u8EMuD6DIC87Z2HaNB5mHIAPoJLpg_-_3ze_CPjBj95Z4fvsAKewhKnjcMNCsPM5-00tsvgjczKqpG_AM1euts</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1881267897</pqid></control><display><type>article</type><title>Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Fong, David ; Grégoire-Gélinas, Pascal ; Cheng, Alexandre P ; Mezheritsky, Tal ; Lavertu, Marc ; Sato, Sachiko ; Hoemann, Caroline D., Ph.D., P.Eng</creator><creatorcontrib>Fong, David ; Grégoire-Gélinas, Pascal ; Cheng, Alexandre P ; Mezheritsky, Tal ; Lavertu, Marc ; Sato, Sachiko ; Hoemann, Caroline D., Ph.D., P.Eng</creatorcontrib><description>Abstract Chitosan is a family of glucosamine and N -acetyl glucosamine polysaccharides with poorly understood immune modulating properties. Here, functional U937 macrophage responses were analyzed in response to a novel library of twenty chitosans with controlled degree of deacetylation (DDA, 60–98%), molecular weight (1 to &gt;100 kDa), and acetylation pattern (block vs. random). Specific chitosan preparations (10 or 190 kDa 80% block DDA and 3, 5, or 10 kDa 98% DDA) either induced macrophages to release CXCL10 and IL-1ra at 5–50 μg/mL, or activated the inflammasome to release IL-1β and PGE2 at 50–150 μg/mL. Chitosan induction of these factors required lysosomal acidification. CXCL10 production was preceded by lysosomal rupture as shown by time-dependent co-localization of galectin-3 and chitosan and slowed autophagy flux, and specifically depended on IFN-β paracrine activity and STAT2 activation that could be suppressed by PGE2 . Chitosan induced a type I IFN paracrine response or inflammasome response depending on the extent of lysosomal rupture and cytosolic foreign body invasion. This study identifies the structural motifs that lead to chitosan-driven cytokine responses in macrophages and indicates that lysosomal rupture is a key mechanism that determines the endogenous release of either IL-1ra or IL-1β.</description><identifier>ISSN: 0142-9612</identifier><identifier>EISSN: 1878-5905</identifier><identifier>DOI: 10.1016/j.biomaterials.2017.03.022</identifier><identifier>PMID: 28340358</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Acetylation ; Advanced Basic Science ; Chemokine CXCL12 - metabolism ; Chitin/chitosan ; Chitosan - chemistry ; Chitosan - pharmacology ; Dentistry ; Dinoprostone - metabolism ; Humans ; Immunomodulation ; Inflammasome ; Inflammasomes - metabolism ; Interferon Type I - metabolism ; Interleukin 1 Receptor Antagonist Protein - metabolism ; Interleukin-1beta - metabolism ; Lysosomes - drug effects ; Lysosomes - pathology ; Macrophage ; Macrophages - drug effects ; Macrophages - metabolism ; Proton Magnetic Resonance Spectroscopy ; Type 1 interferon ; U937 Cells</subject><ispartof>Biomaterials, 2017-06, Vol.129, p.127-138</ispartof><rights>2017 The Authors</rights><rights>Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c553t-24b6342b3abb70c9a7e947595965242c01fc680d3816d18aa259588e82466fd73</citedby><cites>FETCH-LOGICAL-c553t-24b6342b3abb70c9a7e947595965242c01fc680d3816d18aa259588e82466fd73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.biomaterials.2017.03.022$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28340358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fong, David</creatorcontrib><creatorcontrib>Grégoire-Gélinas, Pascal</creatorcontrib><creatorcontrib>Cheng, Alexandre P</creatorcontrib><creatorcontrib>Mezheritsky, Tal</creatorcontrib><creatorcontrib>Lavertu, Marc</creatorcontrib><creatorcontrib>Sato, Sachiko</creatorcontrib><creatorcontrib>Hoemann, Caroline D., Ph.D., P.Eng</creatorcontrib><title>Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages</title><title>Biomaterials</title><addtitle>Biomaterials</addtitle><description>Abstract Chitosan is a family of glucosamine and N -acetyl glucosamine polysaccharides with poorly understood immune modulating properties. Here, functional U937 macrophage responses were analyzed in response to a novel library of twenty chitosans with controlled degree of deacetylation (DDA, 60–98%), molecular weight (1 to &gt;100 kDa), and acetylation pattern (block vs. random). Specific chitosan preparations (10 or 190 kDa 80% block DDA and 3, 5, or 10 kDa 98% DDA) either induced macrophages to release CXCL10 and IL-1ra at 5–50 μg/mL, or activated the inflammasome to release IL-1β and PGE2 at 50–150 μg/mL. Chitosan induction of these factors required lysosomal acidification. CXCL10 production was preceded by lysosomal rupture as shown by time-dependent co-localization of galectin-3 and chitosan and slowed autophagy flux, and specifically depended on IFN-β paracrine activity and STAT2 activation that could be suppressed by PGE2 . Chitosan induced a type I IFN paracrine response or inflammasome response depending on the extent of lysosomal rupture and cytosolic foreign body invasion. This study identifies the structural motifs that lead to chitosan-driven cytokine responses in macrophages and indicates that lysosomal rupture is a key mechanism that determines the endogenous release of either IL-1ra or IL-1β.</description><subject>Acetylation</subject><subject>Advanced Basic Science</subject><subject>Chemokine CXCL12 - metabolism</subject><subject>Chitin/chitosan</subject><subject>Chitosan - chemistry</subject><subject>Chitosan - pharmacology</subject><subject>Dentistry</subject><subject>Dinoprostone - metabolism</subject><subject>Humans</subject><subject>Immunomodulation</subject><subject>Inflammasome</subject><subject>Inflammasomes - metabolism</subject><subject>Interferon Type I - metabolism</subject><subject>Interleukin 1 Receptor Antagonist Protein - metabolism</subject><subject>Interleukin-1beta - metabolism</subject><subject>Lysosomes - drug effects</subject><subject>Lysosomes - pathology</subject><subject>Macrophage</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - metabolism</subject><subject>Proton Magnetic Resonance Spectroscopy</subject><subject>Type 1 interferon</subject><subject>U937 Cells</subject><issn>0142-9612</issn><issn>1878-5905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUs1u1DAQthCILoVXQBYnLgn-SRyHAxJqKVRawQE4W44zy3pJ4uBxKuUpeGUcbUGIEydrPN_PjL4h5AVnJWdcvTqVnQ-jTRC9HbAUjDclkyUT4gHZcd3oom5Z_ZDsGK9E0SouLsgTxBPLNavEY3IhtKyYrPWO_NyvGDCrDTQuc1oiUD_1i4OedivFFBeXP-0wrLT3mPzkEnVHnwLaCSn4dIRI5xjGkACppWmdgXJ6e_ORRsA5TAg0RGpd8nd2g2RCdjgMdhxt9t0KOloXw3y03wCfkkeHvBQ8u38vydebd1-uPhT7T-9vr97uC1fXMhWi6pSsRCdt1zXMtbaBtmrqtm5VLSrhGD84pVkvNVc919aK3NMatKiUOvSNvCQvz7p59h8LYDKjRwfDYCcICxquNReq0e0GfX2G5iERIxzMHP1o42o4M1sg5mT-DsRsgRgmTQ4kk5_f-yzdCP0f6u8EMuD6DIC87Z2HaNB5mHIAPoJLpg_-_3ze_CPjBj95Z4fvsAKewhKnjcMNCsPM5-00tsvgjczKqpG_AM1euts</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Fong, David</creator><creator>Grégoire-Gélinas, Pascal</creator><creator>Cheng, Alexandre P</creator><creator>Mezheritsky, Tal</creator><creator>Lavertu, Marc</creator><creator>Sato, Sachiko</creator><creator>Hoemann, Caroline D., Ph.D., P.Eng</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages</title><author>Fong, David ; Grégoire-Gélinas, Pascal ; Cheng, Alexandre P ; Mezheritsky, Tal ; Lavertu, Marc ; Sato, Sachiko ; Hoemann, Caroline D., Ph.D., P.Eng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c553t-24b6342b3abb70c9a7e947595965242c01fc680d3816d18aa259588e82466fd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acetylation</topic><topic>Advanced Basic Science</topic><topic>Chemokine CXCL12 - metabolism</topic><topic>Chitin/chitosan</topic><topic>Chitosan - chemistry</topic><topic>Chitosan - pharmacology</topic><topic>Dentistry</topic><topic>Dinoprostone - metabolism</topic><topic>Humans</topic><topic>Immunomodulation</topic><topic>Inflammasome</topic><topic>Inflammasomes - metabolism</topic><topic>Interferon Type I - metabolism</topic><topic>Interleukin 1 Receptor Antagonist Protein - metabolism</topic><topic>Interleukin-1beta - metabolism</topic><topic>Lysosomes - drug effects</topic><topic>Lysosomes - pathology</topic><topic>Macrophage</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - metabolism</topic><topic>Proton Magnetic Resonance Spectroscopy</topic><topic>Type 1 interferon</topic><topic>U937 Cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fong, David</creatorcontrib><creatorcontrib>Grégoire-Gélinas, Pascal</creatorcontrib><creatorcontrib>Cheng, Alexandre P</creatorcontrib><creatorcontrib>Mezheritsky, Tal</creatorcontrib><creatorcontrib>Lavertu, Marc</creatorcontrib><creatorcontrib>Sato, Sachiko</creatorcontrib><creatorcontrib>Hoemann, Caroline D., Ph.D., P.Eng</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomaterials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fong, David</au><au>Grégoire-Gélinas, Pascal</au><au>Cheng, Alexandre P</au><au>Mezheritsky, Tal</au><au>Lavertu, Marc</au><au>Sato, Sachiko</au><au>Hoemann, Caroline D., Ph.D., P.Eng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages</atitle><jtitle>Biomaterials</jtitle><addtitle>Biomaterials</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>129</volume><spage>127</spage><epage>138</epage><pages>127-138</pages><issn>0142-9612</issn><eissn>1878-5905</eissn><abstract>Abstract Chitosan is a family of glucosamine and N -acetyl glucosamine polysaccharides with poorly understood immune modulating properties. Here, functional U937 macrophage responses were analyzed in response to a novel library of twenty chitosans with controlled degree of deacetylation (DDA, 60–98%), molecular weight (1 to &gt;100 kDa), and acetylation pattern (block vs. random). Specific chitosan preparations (10 or 190 kDa 80% block DDA and 3, 5, or 10 kDa 98% DDA) either induced macrophages to release CXCL10 and IL-1ra at 5–50 μg/mL, or activated the inflammasome to release IL-1β and PGE2 at 50–150 μg/mL. Chitosan induction of these factors required lysosomal acidification. CXCL10 production was preceded by lysosomal rupture as shown by time-dependent co-localization of galectin-3 and chitosan and slowed autophagy flux, and specifically depended on IFN-β paracrine activity and STAT2 activation that could be suppressed by PGE2 . Chitosan induced a type I IFN paracrine response or inflammasome response depending on the extent of lysosomal rupture and cytosolic foreign body invasion. This study identifies the structural motifs that lead to chitosan-driven cytokine responses in macrophages and indicates that lysosomal rupture is a key mechanism that determines the endogenous release of either IL-1ra or IL-1β.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28340358</pmid><doi>10.1016/j.biomaterials.2017.03.022</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0142-9612
ispartof Biomaterials, 2017-06, Vol.129, p.127-138
issn 0142-9612
1878-5905
language eng
recordid cdi_proquest_miscellaneous_1881267897
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Acetylation
Advanced Basic Science
Chemokine CXCL12 - metabolism
Chitin/chitosan
Chitosan - chemistry
Chitosan - pharmacology
Dentistry
Dinoprostone - metabolism
Humans
Immunomodulation
Inflammasome
Inflammasomes - metabolism
Interferon Type I - metabolism
Interleukin 1 Receptor Antagonist Protein - metabolism
Interleukin-1beta - metabolism
Lysosomes - drug effects
Lysosomes - pathology
Macrophage
Macrophages - drug effects
Macrophages - metabolism
Proton Magnetic Resonance Spectroscopy
Type 1 interferon
U937 Cells
title Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A36%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lysosomal%20rupture%20induced%20by%20structurally%20distinct%20chitosans%20either%20promotes%20a%20type%201%20IFN%20response%20or%20activates%20the%20inflammasome%20in%20macrophages&rft.jtitle=Biomaterials&rft.au=Fong,%20David&rft.date=2017-06-01&rft.volume=129&rft.spage=127&rft.epage=138&rft.pages=127-138&rft.issn=0142-9612&rft.eissn=1878-5905&rft_id=info:doi/10.1016/j.biomaterials.2017.03.022&rft_dat=%3Cproquest_cross%3E1881267897%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1881267897&rft_id=info:pmid/28340358&rft_els_id=1_s2_0_S0142961217301667&rfr_iscdi=true